45 results
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
5:16pm
of the supply chain for raw materials or manufacturing for Surface or the Company’s product candidates, the nature, timing, cost and possible success … and the Company’s respective businesses, operations, supply chain, patient enrollment and retention, preclinical and clinical trials, strategy, goals
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
5:17pm
of the supply chain for raw materials or manufacturing for Surface or the Company’s product candidates, the nature, timing, cost and possible success … on Surface’s and the Company’s respective businesses, operations, supply chain, patient enrollment and retention, preclinical and clinical trials, strategy
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
5:14pm
or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for Surface or the Company’s product … , pandemics or other public health crises and their impact on Surface’s and the Company’s respective businesses, operations, supply chain, patient enrollment
425
SURF
Surface Oncology, Inc.
16 Jun 23
Business combination disclosure
5:14pm
rights; any interruptions of the supply chain for raw materials or manufacturing for Surface or the Company’s product candidates, the nature, timing … and their impact on Surface’s and the Company’s respective businesses, operations, supply chain, patient enrollment and retention, preclinical
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
of the supply chain for raw materials or manufacturing for Coherus or Surface’s product candidates, the nature, timing, cost and possible success … , supply chain, patient enrollment and retention, preclinical and clinical trials, strategy, goals and anticipated milestones. While the foregoing list
8-K
897e9
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
425
d366qouiofuc31fvpxrk
16 Jun 23
Business combination disclosure
5:12pm
425
kt7d2hvtbua8ixvlv
16 Jun 23
Business combination disclosure
5:11pm
425
ko1b6
16 Jun 23
Business combination disclosure
7:09am
425
cry biy55izgl43yy2
16 Jun 23
Business combination disclosure
8:08am
424B5
jgdo9
21 May 18
Prospectus supplement for primary offering
5:20pm
424B5
mb7 e80bwdycvblfr
23 May 18
Prospectus supplement for primary offering
5:27pm
424B5
7qld0efja3qpo4ld4e
17 May 23
Prospectus supplement for primary offering
4:02pm
424B5
9i37bql
16 May 23
Prospectus supplement for primary offering
6:07am